Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04586335
Title Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors ShangHai HaiHe Pharmaceutical
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06519 United States Details
UT Southwestern: Simmons Cancer Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Scientia Cancer Centre Sydney New South Wales 2031 Australia Details
Integrated Oncology Network PTY LTD Brisbane Queensland 4101 Australia Details
Monash Cancer Centre Melbourne Victoria 3168 Australia Details
Fudan University - Pudong Medical Center Shanghai Shanghai China Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field